Gene · 2073
Papers2,901
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,901
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Redox dysregulation as a driver for DNA damage and its relationship to neurodegenerative diseases. | Transl Neurodegener | 2023 | 37055865 | PubTator, text mining | PubMed |
| Atorvastatin Can Modulate DNA Damage Repair in Endothelial Cells Exposed to Mitomycin C. | Int J Mol Sci | 2023 | 37047754 | PubTator, text mining | PubMed |
| R-Loops at Chromosome Ends: From Formation, Regulation, and Cellular Consequence. | Cancers (Basel) | 2023 | 37046839 | PubTator, text mining | PubMed |
| MDCT Diagnosis and Staging of Xanthogranulomatous Pyelonephritis. | Diagnostics (Basel) | 2023 | 37046557 | PubTator, text mining | PubMed |
| Xanthogranulomatous pyelonephritis with polycystic kidney disease as a mimic of cystic renal cell carcinoma: a case report. | BMC Urol | 2023 | 37038156 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Can accelerated ageing models inform us on age-related tauopathies? | Aging Cell | 2023 | 37013265 | PubTator, text mining | PubMed |
| BAP1 as a guardian of genome stability: implications in human cancer. | Exp Mol Med | 2023 | 37009801 | PubTator, text mining | PubMed |
| Single-nucleotide polymorphisms of nucleotide excision repair genes and their association with overall survival in North Indian lung cancer patients treated with platinum-based doublet chemotherapy. | J Cancer Res Ther | 2023 | 37006075 | PubTator, text mining | PubMed |
| A clinical decision support system for AI-assisted decision-making in response-adaptive radiotherapy (ARCliDS). | Sci Rep | 2023 | 37002296 | PubTator, text mining | PubMed |
| Unravelling the clinicopathological and functional significance of replication protein A (RPA) heterotrimeric complex in breast cancers. | NPJ Breast Cancer | 2023 | 36997566 | PubTator, text mining | PubMed |
| Clinical and Mechanistic Implications of R-Loops in Human Leukemias. | Int J Mol Sci | 2023 | 36983041 | PubTator, text mining | PubMed |
DNA Damage Response-Related Proteins Are Prognostic for Outcome in Both Adult and Pediatric Acute Myelogenous Leukemia Patients: Samples from Adults and from Children Enrolled in a Children's Oncology Group Study. | Int J Mol Sci | 2023 | 36982970 | PubTator, text mining | PubMed |
| Prognostication of DNA Damage Response Protein Expression Patterns in Chronic Lymphocytic Leukemia. | Int J Mol Sci | 2023 | 36982555 | PubTator, text mining | PubMed |
| Novel Insights into RAD52's Structure, Function, and Druggability for Synthetic Lethality and Innovative Anticancer Therapies. | Cancers (Basel) | 2023 | 36980703 | PubTator, text mining | PubMed |
| Licochalcone B Induces ROS-Dependent Apoptosis in Oxaliplatin-Resistant Colorectal Cancer Cells via p38/JNK MAPK Signaling. | Antioxidants (Basel) | 2023 | 36978904 | PubTator, text mining | PubMed |
| Roles and mechanisms of exosomal microRNAs in viral infections. | Arch Virol | 2023 | 36977948 | PubTator, text mining | PubMed |
| Genetic analyses of DNA repair pathway associated genes implicate new candidate cancer predisposing genes in ancestrally defined ovarian cancer cases. | Front Oncol | 2023 | 36969007 | PubTator, text mining | PubMed |
Clinical trial on the efficacy and safety of NPC-15 for patients with xeroderma pigmentosum exaggerated sunburn reaction type: XP-1 study protocol for a multicentre, double-blinded, placebo-controlled, two-group crossover study followed by a long-term open study in Japan. | BMJ Open | 2023 | 36948554 | PubTator, text mining | PubMed |
| Xeroderma pigmentosum: case report. | Rev Paul Pediatr | 2023 | 36921168 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2073/papers?page=11